| Literature DB >> 35745040 |
Tiantian Zhao1, Chao Li2, Shuai Wang1, Xinqiang Song1.
Abstract
Objectives Green tea (Camellia sinensis) is a kind of unfermented tea that retains the natural substance in fresh leaves to a great extent. It is regarded as the second most popular drink in the world besides water. In this paper, the phytochemistry, pharmacology, and toxicology of green tea are reviewed systematically and comprehensively. Key findings Green tea has been demonstrated to be good for human health. Nowadays, multiple pharmacologically active components have been isolated and identified from green tea, including tea polyphenols, alkaloids, amino acids, polysaccharides, and volatile components. Recent studies have demonstrated that green tea shows versatile pharmacological activities, such as antioxidant, anticancer, hypoglycemic, antibacterial, antiviral, and neuroprotective. Studies on the toxic effects of green tea extract and its main ingredients have also raised concerns including hepatotoxicity and DNA damage. Summary Green tea can be used to assist the treatment of diabetes, Alzheimer's disease, oral cancer, and dermatitis. Consequently, green tea has shown promising practical prospects in health care and disease prevention.Entities:
Keywords: green tea; human health; pharmacology; phytochemistry; toxicology; unfermented tea
Mesh:
Substances:
Year: 2022 PMID: 35745040 PMCID: PMC9231383 DOI: 10.3390/molecules27123909
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Chemical structures of catechins isolated from green tea.
Figure 2Chemical structures of flavonoids isolated from green tea.
Figure 3Chemical structures of anthocyanins isolated from green tea.
Figure 4Chemical structures of phenolic acids isolated from green tea.
Figure 5Chemical structures of alkaloids isolated from green tea.
Figure 6Chemical structures of amino acids isolated from green tea.
Figure 7Chemical structures of aromatic ingredients isolated from green tea.
Figure 8Chemical structures of organic acids isolated from green tea.
Pharmacological effects of green tea.
| Pharmacological Effects | Detail | Extracts/Compounds | Minimal Active Concentration/Dose | In Vitro/In Vivo | Refs. |
|---|---|---|---|---|---|
| Antioxidant effects | Inhibiting copper-catalyzed low-density lipoprotein (LDL) lipid peroxidation | Tea polyphenols | 0.1 μg/mL | In vitro | [ |
| Scavenging DPPH radicals | EGCG, ECG, EGC, and EC | EC50 = 0.03, 0.04, 0.07, and 0.10 mol/mol | In vitro | [ | |
| Scavenging total oxy-radicals | ECG and EGCG | 0.348 ± 0.012, and 0.374 ± 0.020 TOSC/ μM | In vitro | [ | |
| Scavenging superoxide radicals | TLPS, TFPS and TSPS | 0.5 μg/mL~100 μg/mL | In vitro | [ | |
| Increasing the activity of antioxidant enzymes | Green tea extract | 125, 625 and 1250 mg/kg (i.g., for four weeks) | In vivo | [ | |
| Protecting against hepatotoxicity caused by excess acetaminophen (APAP) in mice | Green tea extract | 10 mg/L | In vivo | [ | |
| Anticancer effects | Inhibiting migration and invasion of tumor cells inhibited the growth of HeLa cells | EGCG | IC50 = 57.2%, and 29.3%, (48 h), respectively | In vitro | [ |
| Inhibiting lung and liver metastasis in BALB/c mice with 4T1 tumors | Green tea extract | 0.06~0.125 mg/mL, respectively | In vivo | [ | |
| Inducing apoptosis in colon cancer cells by modulating Akt, ERK1/2 and p38 MAPK signaling pathways | EGCG | 100 or 200 μM | In vitro | [ | |
| Inducing apoptosis in ovarian cells | Green tea extract | 0.1, 1, 10, 100, and 200 μg/mL, respectively | In vitro | [ | |
| Inhibiting the growth of HuH7 cells and HCC cells | EGCG | IC50 = 25, 84 μg/mL, respectively | In vitro | [ | |
| Inhibiting the growth of androgen-sensitive and androgen-sensitive human prostate cancer cells (PCA) | EGCG | 10 µg/mL~80 µg/mL | In vitro | [ | |
| Inhibiting the growth of gastric cancer cell line NCI-N87 in a time- and dose-dependent manner | EGCG | 0~100 μM | In vitro | [ | |
| Inhibiting the growth of oral cancer tumors | Green tea polyphenols | 200 mg/kg | In vitro | [ | |
| Inhibiting cyclooxygenase-2 in non-small cell lung cancer cells | Green tea polyphenols | 0, 10, 20, and 40 μg/mL, respectively | In vitro | [ | |
| Anti-diabetic effects | Increasing insulin sensitivity in rats | Green tea polyphenols | 0.75% | In vivo | [ |
| Improving insulin sensitivity and lipid distribution | Green tea extract | 80 mg/kg (i.g., for 12 weeks) | In vivo | [ | |
| Improving glucose metabolism | Green tea extract | 75 mg/kg (i.g., for 30 days) | In vivo | [ | |
| Promoting insulin secretion | The water-soluble polysaccharide 7WA | 50 µg/mL~200 µg/mL | In vitro | [ | |
| Alleviating maternal diabetes-induced neural tube defects | EGCG | 10 µM | In vivo | [ | |
| Antibacterial effects | Inhibiting Helicobacter pylori activity | EGCG | MIC90 = 50~100 μg/ml | In vitro | [ |
| Inhibiting the survival of Mycobacterium tuberculosis in macrophages | EGCG | 0~60 μg/mL | In vitro | [ | |
| Inhibiting S. aureus activity | EGCG | MIC90 = 58 mg/L | In vitro | [ | |
| Inhibiting skin pathogens activity | Green tea extract | MIC = 0.156~0.313 mg /mL | In vitro | [ | |
| Inhibiting Porphyromonas gingivalis activity | Green tea extract and EGCG | MIC = 250~1000 mg/mL, 125~500 mg/mL, respectively | In vitro | [ | |
| Antiviral effects | Inhibiting HIV-1 integrase activity | EGCG and GC | IC50 = 0.96, 0.56 μmol/L, respectively | In vitro | [ |
| Inhibiting influenza A virus activity | EGCG | EC50 = 22~28 μM | In vitro | [ | |
| Inhibiting the production of hepatitis B virus (HBV) | Green tea extract | EC50 = 5.02, 5.681, 19.8, and 10.76 μg/mL, respectively | In vitro | [ | |
| Inactivating the Foodborne viruses, such as human Novo virus (NoV) and hepatitis A virus (HAV) | Green tea extract | 10 mg/mL (for 30 min) | In vitro | [ | |
| Inhibiting ZIKV entry into host cells | EGCG | Not mentioned | In vitro | [ | |
| Neuroprotective effects | Improve learning and memory in aged rats through the antioxidant defense | Green tea extract | 0.5% (i.g., for 8 weeks) | In vivo | [ |
| Improve memory and hippocampal LTP in AD mice through the dopamine D1/5-PKA pathway | L-theanine | 12.5 μM~50 μM | In vivo | [ | |
| Neuroprotective effect on neurotoxins in mice and rat | EGCG | Not mentioned | In vivo | [ | |
| Protect dopamine neurons in 6-OHDA-treated PD rat models | Green tea polyphenols | 450 mg/kg/day | In vitro | [ | |
| Improve nerve redox imbalance and mitochondrial dysfunction by regulating circadian rhythm | Green tea polyphenols | 10, 20, and 40 µg/mL, respectively | In vitro | [ | |
| Reduce neuronal damage after cerebral ischemia | EGCG | 50 mg/kg | In vivo | [ | |
| Improve the spatial cognitive ability after chronic cerebral hypoperfusion | Green tea polyphenols | 400 mg/kg | In vivo | [ | |
| Inhibiting HO-1 expression and activating ERK1/2 pathway | Theanine | 1 mg/kg | In vivo | [ | |
| Reduces (DDT)-induced cell death in dopaminergic SHSY-5Y cells | EGCG | 1, 3 and 10 µM | In vitro | [ | |
| Protecting against lead-induced brain oxidation and DNA damage in rats | Green tea extract | 5 g/L | In vivo | [ | |
| Improve cognitive impairment caused by isoflurane by regulating oxidative stress | Green tea polyphenols | 25 mg/kg (i.g., for 7 days) | In vivo | [ | |
| Effects on the immune system | Inhibit the proliferation of spleen T cells in C57BL mice | EGCG | 2.5 μM~10 μM | In vivo | [ |
| Inducing regulatory T cells | EGCG | 2%, | In vitro | [ | |
| Reduce the mortality of mice with anaphylactic shock induced by compound C48/80 | Green tea extract | 11, 13, and 15 mg/mL | In vivo | [ | |
| Improve T-cell-mediated autoimmune diseases | EGCG | 0.3% | In vivo | [ | |
| Other pharmacological effects | Inhibited the mutagenicity of tobacco in a concentration-dependent manner | Green tea polyphenols | 50 mg/plate | In vitro | [ |
| Anti-thyroid effect | Green tea extract | 1.25 g%, | In vivo | [ | |
| Diuretic activity | Green tea extract | 100~500 mg/mL | In vivo | [ | |
| Bone-protective effect | green tea polyphenols | 0.1% or 0.5% concentration | In vivo | [ | |
| Anti-protozoal Leishmania effect | EGCG and ECG | IC50 = 27.7, 75 μM, respectively | In vitro | [ |
Figure 9Pharmacological effects of green tea.